0001104659-20-072742.txt : 20200612
0001104659-20-072742.hdr.sgml : 20200612
20200612114757
ACCESSION NUMBER: 0001104659-20-072742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200612
DATE AS OF CHANGE: 20200612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harshbarger Benjamin
CENTRAL INDEX KEY: 0001653133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 20959472
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2020-06-11
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001653133
Harshbarger Benjamin
C/O CATABASIS PHARMACEUTICALS, INC.,
100 HIGH STREET, FLOOR 28
BOSTON
MA
02110
0
1
0
0
Secretary and General Counsel
Stock Option (right to buy)
6.17
2020-06-11
4
A
0
45000
0
A
2030-06-10
Common Stock
45000
45000
D
This option was granted on June 11, 2020 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of June 8, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
/s/ Jill Milne, as attorney-in-fact for Benjamin Harshbarger
2020-06-12